Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Cosmo Pharmaceuticals NV"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -8.29% vs 45.80% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -92.61% vs -24.79% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "94.00",
          "val2": "102.50",
          "chgp": "-8.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.50",
          "val2": "40.20",
          "chgp": "-73.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.50",
          "val2": "9.30",
          "chgp": "-51.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.30",
          "val2": "17.60",
          "chgp": "-92.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "111.40%",
          "val2": "256.30%",
          "chgp": "-14.49%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

94.00

102.50

-8.29%

Operating Profit (PBDIT) excl Other Income

10.50

40.20

-73.88%

Interest

4.50

9.30

-51.61%

Exceptional Items

0.00

-0.00

Consolidate Net Profit

1.30

17.60

-92.61%

Operating Profit Margin (Excl OI)

111.40%

256.30%

-14.49%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is -8.29% vs 45.80% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -92.61% vs -24.79% in Dec 2022

All Annual Results